Patents Assigned to Pharmacia Genetic Engineering, Inc.
  • HIV antibody assays comprising p24-gp41 chimeric antigens
    Patent number: 5470720
    Abstract: The present invention relates to a DNA segment encoding a recombinant HIV p24 protein or HIV p24-gp41 fusion protein and a recombinant DNA (rDNA) molecule capable of expressing either protein. Cells transformed with the rDNA, methods for producing the fusion protein and diagnostic methods and systems using the fusion protein are also described.
    Type: Grant
    Filed: April 20, 1993
    Date of Patent: November 28, 1995
    Assignee: Pharmacia Genetic Engineering Inc.
    Inventors: Torsten B. Helting, Hakan Drevin, Michael F. Nunn
  • Methods and systems for producing HIV antigens
    Patent number: 5204259
    Abstract: The present invention relates to a DNA segment encoding a recombinant HIV p24 protein or HIV p24-gp41 fusion protein and a recombinant DNA (rDNA) molecule capable of expressing either protein. Cells transformed with the rDNA, methods for producing the fusion protein and diagnostic methods and systems using the fusion protein are also described.
    Type: Grant
    Filed: April 26, 1989
    Date of Patent: April 20, 1993
    Assignee: Pharmacia Genetic Engineering, Inc.
    Inventors: Torsten B. Helting, Hakan Drevin, Michael F. Nunn